BDBM62559 MLS000031545::N-[2-(3,5-Dimethyl-pyrazol-1-yl)-2-oxo-ethyl]-2-phenyl-acetamide::N-[2-(3,5-dimethyl-1-pyrazolyl)-2-oxoethyl]-2-phenylacetamide::N-[2-(3,5-dimethylpyrazol-1-yl)-2-keto-ethyl]-2-phenyl-acetamide::N-[2-(3,5-dimethylpyrazol-1-yl)-2-oxidanylidene-ethyl]-2-phenyl-ethanamide::N-[2-(3,5-dimethylpyrazol-1-yl)-2-oxoethyl]-2-phenylacetamide::SMR000011650::cid_652231

SMILES COCCN1Cc2cc(N3CCCc4cc(C(=O)N5CCCCC5)cnc43)ccc2C1=O

InChI Key InChIKey=DILXWBSKYKBENJ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62559   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62559BDBM62559(US12577217, Example 1-64)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent